Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Drug Insights
4 min read
Temsirolimus: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
27 September 2023
This article summarized the latest R&D progress of Temsirolimus, the Mechanism of Action for Temsirolimus, and the drug target R&D trends for Temsirolimus.
Bio Sequence
3 min read
CAR-T Core Functional Component Sequence Retrieval Strategy
27 September 2023
Chimeric antigen receptor (CAR) T cell therapy, in which a patient’s own T lymphocytes are engineered to recognize and kill cancer cells, has achieved remarkable success in some hematological malignancies in preclinical and clinical trials.
Drug Insights
4 min read
An In-depth Analysis of Hydroxycarbamide's R&D Progress and Mechanism of Action on Drug Target
27 September 2023
This article summarized the latest R&D progress of Hydroxycarbamide, the Mechanism of Action for Hydroxycarbamide, and the drug target R&D trends for Hydroxycarbamide.
Latest Hotspot
3 min read
The FDA expedites reviewing Merck's request to use KEYTRUDA®, alongside chemoradiotherapy, for cervical cancer treatment
27 September 2023
Merck has reported that the U.S. FDA is conducting a priority analysis on a fresh sBLA petitioning for authorization of KEYTRUDA, Merck’s anti-PD-1 treatment.
Drug Insights
4 min read
Gossypol Unveiled: A Detailed Overview of its Revolutionary R&D Breakthroughs
27 September 2023
This article summarized the latest R&D progress of Gossypol, the Mechanism of Action for Gossypol, and the drug target R&D trends for Gossypol.
Valuable Targets
5 min read
Advances in Clinical Research on Cholinesterase Inhibitors
27 September 2023
Cholinesterase is a class of glycoprotein that is present in the body in various isoenzyme forms. It can be generally divided into true cholinesterase and pseudocholinesterase.
Drug Insights
4 min read
Unleashing the Power of Glecaprevir/Pibrentasvir: A Comprehensive Review on R&D Breakthroughs
27 September 2023
This article summarized the latest R&D progress of Glecaprevir/Pibrentasvir, the Mechanism of Action for Glecaprevir/Pibrentasvir, and the drug target R&D trends for Glecaprevir/Pibrentasvir.
Latest Hotspot
3 min read
The Menarini Group's ORSERDU® (Elacestrant) has received approval from the EC for breast cancer
27 September 2023
The Menarini Group,together with their fully owned subsidiary Stemline Therapeutics Inc., declared that ORSERDU® (elacestrant) has received authorisation from the European Commission.
Drug Insights
4 min read
A Comprehensive Review of Ganaxolone's R&D Innovations and Drug Target Mechanism
26 September 2023
This article summarized the latest R&D progress of Ganaxolone, the Mechanism of Action for Ganaxolone, and the drug target R&D trends for Ganaxolone.
Valuable Targets
6 min read
The Body's Inflammatory Messengers: COX-2 Inhibitors
26 September 2023
Cyclooxygenase, also known as Prostaglandin-endoperoxide Synthase, is a bifunctional enzyme with both cyclooxygenase and peroxidase activity.
Drug Insights
4 min read
Pharmaceutical Insights: Gabapentin Enacarbil's R&D Progress and its Mechanism of Action on Drug Target
26 September 2023
This article summarized the latest R&D progress of Gabapentin Enacarbil, the Mechanism of Action for Gabapentin Enacarbil, and the drug target R&D trends for Gabapentin Enacarbil.
"What" Series
2 min read
What is CRC in Life Sciences?
26 September 2023
The CRC is responsible for drafting product clinical plans, implementing clinical trials, monitoring clinical research quality, tracking research progress, and coordinating clinical trial work.